CliffBio
small molecule

BREKIYA (AUTOINJECTOR)

DIHYDROERGOTAMINE MESYLATE

Loss of exclusivityAugust 2039latest FDA-listed patent expiry
CompanyAmneal Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameBREKIYA (AUTOINJECTOR)
Active ingredientDIHYDROERGOTAMINE MESYLATE
Strength1MG/ML
Dosage formSOLUTION
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalMay 2025
Marketing statusRX

Listed patents

PatentExpiresType
12414941August 2039product
11083712June 2039product
12329749May 2039product
11541043March 2039product
11304942February 2039product
10532049February 2039product
12533351February 2039product
11819501February 2039use U-4188

More from Amneal Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

BREKIYA (AUTOINJECTOR) patent cliff — loss of exclusivity August 2039 | CliffBio